Rasio rega marang prakiraan pendapatan Simulations Plus (SLP)
The expected P/S of Simulations Plus, Inc. is rising amid expanding demand for biosimulations within the biotech sector. This positive trend is based on the FDA's absolute confidence in the predictive accuracy of Simulations Plus, Inc. and the scalability of its AI platform for virtual testing. The current 4.60 metric defines this level, allowing market noise to be separated from the real value of the US exporter.
Rincian metrik komprehensif lan analitis Simulations Plus Inc. (SLP)
- rega saiki lan proyeksi nilai saham:
- rincian kapitalisasi pasar:
- indikator nilai buku ekuitas:
- data utang lan likuiditas:
Rasio Total Utang marang Ekuitas Simulations Plus, Inc.|SLP - Koefisien utang jangka dawa marang modal|Utang jangka cendhak marang ekuitas Simulations Plus, Inc.|SLP - Gunggung tanggungan utang perusahaan|Rasio utang marang kapitalisasi buku Simulations Plus Inc.|SLP - Utang jangka dawa perusahaan|Kewajiban jangka cendhak perusahaan Simulations Plus|Likuiditas cepet simulations-plus.com
- data bathi bisnis lan rasio investasi:
SLP - Asil keuangan resik|Bathi mangsa ngarep Simulations Plus, Inc.|SLP - Nilai perusahaan marang bathi resik|Pangali Forward P/E Simulations Plus Corp|SLP - Kapitalisasi marang bathi resik kanthi nimbang wutah|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Simulations Plus Inc.|SLP - Bathi operasional sadurunge amortisasi|Bathi resik saben saham (EPS TTM) Simulations Plus|SLP - Bathi resik saben saham sajrone 12 wulan pungkasan|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan simulations-plus.com|SLP - Prakiraan wutah bathi resik saben saham ing taun iki|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Simulations Plus, Inc.
- indikator dodolan lan pendapatan:
Pambiji fundamental:SLP (Simulations Plus)
Simulations Plus, Inc. (SLP) leadership in AI-driven pharmaceutical modeling makes revenue a key value driver, which is assessed via the forward P/S ratio. This multiple compares market capitalization to projected sales, allowing investors to determine the premium paid for future growth. A decline in values on the Simulations Plus, Inc. (SLP) forward P/S chart signals potential business undervaluation, provided management's expansion rates remain stable.
Karo sapa Simulations Plus, Inc. saingan
Multiplikator Forward P/S VEEV (Veeva)|Rasio kapitalisasi marang dodolan sing dikarepake Doximity Inc (DOCS)|HQY - Rasio rega marang prakiraan pendapatan|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Waystar Corp|CorVel Corporation (CRVL) - Rasio rega marang prakiraan pendapatan|Kapitalisasi marang prakiraan pendapatan PRVA|Rasio rega marang prakiraan pendapatan Huron|Certara Inc (CERT) - Rasio kapitalisasi marang dodolan sing dikarepake|Multiplikator forward rega marang pendapatan OMCL (Omnicell Corp)|GDRX (GoodRx Gold) - Rega forward marang dodolan|Rasio rega marang prakiraan pendapatan Schrodinger, Inc. SDGR|PHR (phreesia.com) - Rega mangsa ngarep marang pendapatan|OMDA - Rasio rega marang prakiraan pendapatan|EVH: Rasio rega marang prakiraan pendapatan|HSTM (HealthStream Corp) - Multiplikator forward rega marang pendapatan|Definitive Corp (DH) - Multiplikator Forward P/S|Rasio rega marang prakiraan pendapatan Consensus Cloud Solutions|agilonhealth.com (AGL) - Rasio kapitalisasi marang dodolan sing dikarepake|Multiplikator forward rega marang pendapatan ABSI (Absci Corporation)|SY (So-Young International Inc) - Rega forward marang dodolan|Multiplikator Forward P/S NRC (National Research Corporation)|Rasio kapitalisasi marang dodolan sing dikarepake USA Mobility (SPOK)|OPRX - Rasio rega marang prakiraan pendapatan|TBRG (trubridge.com) - Kapitalisasi marang prakiraan pendapatan|SOPH: Multiplikator Forward P/S|Multiplikator forward rega marang pendapatan Health Catalyst Inc.|Multiplikator forward rega marang pendapatan CCLD|Research Solutions Inc. (RSSS) - Rasio kapitalisasi marang dodolan sing dikarepake|Rasio rega marang prakiraan pendapatan DLH Holdings Corp. (DLHC)|Rasio kapitalisasi marang dodolan sing dikarepake onemednet.com|Rasio rega marang prakiraan pendapatan Scienture SCNX|Healthcare Triangle Inc - Rasio rega marang prakiraan pendapatan|ISPC - Rasio rega marang prakiraan pendapatan|Rega mangsa ngarep marang pendapatan BFRG|WORX: Multiplikator Forward P/S|MSPR - Rasio kapitalisasi marang dodolan sing dikarepake|Multiplikator forward rega marang pendapatan ICCT|MEDS (TRxADE HEALTH Inc) - Rasio rega marang pendapatan sing dikarepake|Multiplikator forward rega marang pendapatan ORGS (Orgenesis Corp)|RCM (r1rcm.com) - Rega forward marang dodolan|Rasio rega marang prakiraan pendapatan Sharecare, Inc. SHCR|STRM - Multiplikator forward rega marang pendapatan|Syra Health - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Apollo Medical Holdings|MODN: Multiplikator Forward P/S|Kapitalisasi marang prakiraan pendapatan NXGN
